Name: Exopharm (EX1) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

EX1

Pharmaceuticals, Biotechnology & Life Sciences

Exopharm

Short interest: 0.00%; −0.01 pp 30d; as of 12 Dec 2022
Reported shorts: 6.5K
Shares on issue: 157.212M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Exopharm

Exopharm Limited is an Australian biopharmaceutical company dedicated to the research, development, and commercialisation of exosomes as a novel class of therapeutic agents. The company leverages its proprietary LEAP (Ligand-based Exosome Affinity Purification) manufacturing technology to enable scalable and high-purity production of exosomes. This positions Exopharm to address significant unmet medical needs across various disease areas by delivering exosome-based medicines.

Company profile →

Exopharm (ASX:EX1) has 0.00% of its shares on issue reported as short positions as of 12 Dec 2022, or about 6,497 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.10% in August 2021. EX1 is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.